EEM syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1897OMIM:225280Q87.8
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

EEM syndrome (Ectodermal dysplasia, Ectrodactyly, and Macular dystrophy syndrome) is an extremely rare autosomal recessive genetic disorder characterized by the triad of ectodermal dysplasia, ectrodactyly (split hand/foot malformation), and macular dystrophy of the eye. The condition affects multiple body systems including the skin and its appendages (ectodermal structures), the limbs, and the eyes. Ectodermal dysplasia features include sparse hair (hypotrichosis), abnormal or absent teeth (hypodontia or anodontia), and dry skin. Ectrodactyly manifests as lobster-claw deformity of the hands and/or feet, with absence or fusion of central digits. The macular dystrophy component involves progressive degeneration of the central retina, which can lead to significant visual impairment. EEM syndrome has been linked to mutations in the CDH3 gene, which encodes P-cadherin, a calcium-dependent cell adhesion protein important in the development of ectodermal tissues, limb formation, and retinal pigment epithelium. Only a small number of families have been reported worldwide, predominantly from consanguineous backgrounds, consistent with its autosomal recessive inheritance pattern. There is currently no cure or disease-specific treatment for EEM syndrome. Management is supportive and multidisciplinary, involving dermatologists for skin care, dentists or prosthodontists for dental abnormalities, orthopedic surgeons for limb malformations, and ophthalmologists for monitoring and managing macular dystrophy. Low-vision aids may be beneficial for patients with significant visual loss. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Selective tooth agenesisHP:0001592Macular dystrophyHP:0007754EctrodactylyHP:0100257
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for EEM syndrome.

View clinical trials →

No actively recruiting trials found for EEM syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the EEM syndrome community →

Specialists

2 foundView all specialists →
TM
Terence O'Brien, MD
Specialist
PI on 1 active trial
ZA
Zina Maria A de Azevedo
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to EEM syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open EEM syndromeForum →

No community posts yet. Be the first to share your experience with EEM syndrome.

Start the conversation →

Latest news about EEM syndrome

No recent news articles for EEM syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about EEM syndrome

What is EEM syndrome?

EEM syndrome (Ectodermal dysplasia, Ectrodactyly, and Macular dystrophy syndrome) is an extremely rare autosomal recessive genetic disorder characterized by the triad of ectodermal dysplasia, ectrodactyly (split hand/foot malformation), and macular dystrophy of the eye. The condition affects multiple body systems including the skin and its appendages (ectodermal structures), the limbs, and the eyes. Ectodermal dysplasia features include sparse hair (hypotrichosis), abnormal or absent teeth (hypodontia or anodontia), and dry skin. Ectrodactyly manifests as lobster-claw deformity of the hands an

How is EEM syndrome inherited?

EEM syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does EEM syndrome typically begin?

Typical onset of EEM syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat EEM syndrome?

2 specialists and care centers treating EEM syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.